Advanced Enzyme Technologies LimitedADVENZYMESNSE
Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an…
As filed · Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an additional investment of ₹ 2.5 million in the wholly owned subsidiaryof the Company Adva
CapitalImprovingNotablemateriality 69 out of 100
What happened
FactThe company has completed an additional investment of ₹2.5 million in its wholly owned subsidiary, Advanced Nutrazyme Private Limited, through a rights issue of 250,000 equity shares at ₹10 each. This brings the total investment in the subsidiary to ₹3 million, consisting of 300,000 equity shares at ₹10 each.
Why it matters
CapitSignal interpretationExisting holders can maintain their stake only by putting in more money; those who do not subscribe are diluted.
Watch next
Fact- Rights ratio and issue price
- Record date and subscription window
- Promoter intention to subscribe
Evidence
How CapitSignal classified this
- Reasoning:
- RIGHTS_ISSUE base 64; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%